Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O5KK
|
||||
Former ID |
DNC008397
|
||||
Drug Name |
7,8,9,10-tetrahydro-6H-furo-[2,3-g][3]benzazepine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529221] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H13NO
|
||||
Canonical SMILES |
C1CNCCC2=C1C=CC3=C2OC=C3
|
||||
InChI |
1S/C12H13NO/c1-2-10-5-8-14-12(10)11-4-7-13-6-3-9(1)11/h1-2,5,8,13H,3-4,6-7H2
|
||||
InChIKey |
QDAAIWYKQLAISZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [529221] | |
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [529221] | ||
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [529221] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.